Evidence for the involvement of VAR2CSA in pregnancy-associated malaria

Ali Salanti, Madeleine Dahlbäck, Louise Turner, Morten A Nielsen, Lea Barfod, Pamela Magistrado, Anja T R Jensen, Thomas Lavstsen, Michael F Ofori, Kevin Marsh, Lars Hviid, Thor G Theander

406 Citations (Scopus)

Abstract

In Plasmodium falciparum-endemic areas, pregnancy-associated malaria (PAM) is an important health problem. The condition is precipitated by accumulation of parasite-infected erythrocytes (IEs) in the placenta, and this process is mediated by parasite-encoded variant surface antigens (VSA) binding to chondroitin sulfate A (CSA). Parasites causing PAM express unique VSA types, VSAPAM, which can be serologically classified as sex specific and parity dependent. It is sex specific because men from malaria-endemic areas do not develop VSAPAM antibodies; it is parity dependent because women acquire anti-VSAPAM immunoglobulin (Ig) G as a function of parity. Previously, it was shown that transcription of var2csa is up-regulated in placental parasites and parasites selected for CSA binding. Here, we show the following: (a) that VAR2CSA is expressed on the surface of CSA-selected IEs; (b) that VAR2CSA is recognized by endemic plasma in a sex-specific and parity-dependent manner; (c) that high anti-VAR2CSA IgG levels can be found in pregnant women from both West and East Africa; and (d) that women with high plasma levels of anti-VAR2CSA IgG give birth to markedly heavier babies and have a much lower risk of delivering low birth weight children than women with low levels.
Original languageEnglish
JournalJournal of Experimental Medicine
Volume200
Issue number9
Pages (from-to)1197-203
Number of pages6
ISSN0022-1007
DOIs
Publication statusPublished - 2004

Fingerprint

Dive into the research topics of 'Evidence for the involvement of VAR2CSA in pregnancy-associated malaria'. Together they form a unique fingerprint.

Cite this